Prostaglandins, H2-Receptor Antagonists and Peptic Ulcer Disease Peter Bright-AsareTsega HabteJames Benjamin Section 1: Clinical Considerations 15 November 2012 Pages: 1 - 9
The Significance of Gastrin in the Pathogenesis and Therapy of Peptic Ulcer Disease C. B. H. W. Lamers Section 1: Clinical Considerations 15 November 2012 Pages: 10 - 16
Antisecretory Drugs M. J. S. Langman Section 1: Clinical Considerations 15 November 2012 Pages: 17 - 19
The Use of Roxatidine Acetate in Fasting Patients Prior to Induction of Anaesthesia as Prophylaxis against the Acid Aspiration Syndrome Michael TrybaG. WruckM. Zenz Section 1: Clinical Considerations 15 November 2012 Pages: 20 - 24
Comparative Pharmacology of Histamine H2-Receptor Antagonists K.-Fr. SewingW. BeilH. Hannemann Section 2: Animal Pharmacology of Roxatidine Acetate 15 November 2012 Pages: 25 - 29
A Review of the Animal Pharmacology of Roxatidine Acetate J. ScholtholtM. BickelA. W. Herling Section 2: Animal Pharmacology of Roxatidine Acetate 15 November 2012 Pages: 30 - 40
Pharmacokinetics of Roxatidine in Healthy Volunteers J. D. CollinsA. W. Pidgen Section 3: Clinical Pharmacology of Roxatidine Acetate 15 November 2012 Pages: 41 - 47
A Pharmacokinetic Study of Roxatidine Acetate in Chronic Renal Failure N. LameireB. RosenkranzD. Brockmeier Section 3: Clinical Pharmacology of Roxatidine Acetate 15 November 2012 Pages: 48 - 52
The Pharmacodynamics and Pharmacokinetics of Multiple Doses of the New H2-Receptor Antagonist, Roxatidine Acetate, in Healthy Men Howard B. LassmanIrwin HoMichael R. Scheffler Section 3: Clinical Pharmacology of Roxatidine Acetate 15 November 2012 Pages: 53 - 64
Effect of Roxatidine Acetate on Daytime and Night-Time Peptone-Stimulated Gastric Acid Secretion F. Hagenmüller Section 3: Clinical Pharmacology of Roxatidine Acetate 15 November 2012 Pages: 65 - 68
The Effects of Roxatidine Acetate on 24-Hour Intragastric Acidity H. S. MerkiL. WitzelR. P. Walt Section 3: Clinical Pharmacology of Roxatidine Acetate 15 November 2012 Pages: 69 - 75
Effects of Roxatidine Acetate on 24-Hour Gastric Acidity P. HemeryP. CongardS. Bonfils Clinical Pharmacology of Roxatidine Acetate 15 November 2012 Pages: 76 - 81
Interaction of Roxatidine Acetate with Antacids, Food and Other Drugs Rotraut A. Labs Section 3: Clinical Pharmacology of Roxatidine Acetate 15 November 2012 Pages: 82 - 89
A Comparison of Roxatidine Acetate and Ranitidine in Duodenal Ulcer Healing W. Hüttemann Section 4: Roxatidine Acetate in Doudenal Ulcer 15 November 2012 Pages: 90 - 95
A Comparison of Roxatidine Acetate 150mg Once Daily and 75mg Twice Daily in Duodenal Ulcer Healing E. HentschelK. Schützemembers of the International Cooperative Roxatidine Study Group Section 4: Roxatidine Acetate in Doudenal Ulcer 15 November 2012 Pages: 96 - 101
Roxatidine Acetate in the Long Term Maintenance of Duodenal Ulcers G. Brunner Section 4: Roxatidine Acetate in Doudenal Ulcer 15 November 2012 Pages: 102 - 105
Optimal Reduction of Gastric Acid Secretion in the Treatment of Peptic Ulceration H. G. DammannM. DreyerB. Simon Section 4: Roxatidine Acetate in Doudenal Ulcer 15 November 2012 Pages: 106 - 113
Clinical Studies on the Use of Roxatidine Acetate for the Treatment of Peptic Ulcer in Japan Masaki Inoue Section 4: Roxatidine Acetate in Doudenal Ulcer 15 November 2012 Pages: 114 - 119
A Comparison of Roxatidine Acetate and Ranitidine in Gastric Ulcer Healing G. Judmaier Section 5: Roxatidine Acetate in Gastric Ulcer 15 November 2012 Pages: 120 - 126
A Comparison of Roxatidine Acetate 150mg Once Daily and 75mg Twice Daily in Gastric Ulcer Healing W. Rösch Section 5: Roxatidine Acetate in Gastric Ulcer 15 November 2012 Pages: 127 - 133
Roxatidine Acetate in the Long Term Maintenance of Gastric Ulcers G. Börsch Section 5: Roxatidine Acetate in Gastric Ulcer 15 November 2012 Pages: 134 - 138
Closing Remarks M. Classen Section 5: Roxatidine Acetate in Gastric Ulcerer 15 November 2012 Pages: 139 - 139
Appendix 1 Therapeutic Resistance of Peptic Ulcers M. Classen Section 5: Roxatidine Acetate in Gastric Ulcer 15 November 2012 Pages: 140 - 142